Paul Tudor Jones Cerus Corp Transaction History

Tudor Investment Corp Et Al

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$1.66 - $2.42 $40,875 - $59,590	24,624 New	24,624 $46,000
Q1 2022 May 16, 2022	SELL	$4.81 - $6.99 $337,123 - $489,915	-70,088 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$5.97 - $7.93 $151,315 - $200,993	-25,346 Reduced 26.56%	70,088 $477,000
Q3 2021 Nov 15, 2021	BUY	$4.79 - $6.68 $213,159 - $297,266	44,501 Added 87.37%	95,434 $581,000
Q2 2021 Aug 16, 2021	BUY	$5.35 - $6.35 $272,491 - $323,424	50,933 New	50,933 $301,000
Q1 2020 May 15, 2020	SELL	$2.87 - $5.49 $41,709 - $79,786	-14,533 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$3.84 - $4.86 $55,806 - $70,630	14,533 New	14,533 $61,000
Q3 2019 Nov 14, 2019	SELL	$4.86 - $6.05 $268,111 - $333,760	-55,167 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$4.51 - $6.6 $248,803 - $364,102	55,167 New	55,167 $310,000
Q1 2019 May 15, 2019	SELL	$5.16 - $6.85 $135,682 - $180,120	-26,295 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$4.89 - $7.16 $48,112 - $70,447	9,839 Added 59.79%	26,295 $133,000
Q3 2018 Nov 14, 2018	BUY	$6.89 - $7.78 $113,381 - $128,027	16,456 New	16,456 $119,000

160

144M

22.5K

23.6K

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $328M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.